Mundi Pharma files patent case against Hana Pharm in Korea

Published: 2009-07-08 06:57:00

Updated: 2009-07-08 06:57:00

Switzerland based Mundi Pharma Laboratories has filed a lawsuit in the Seoul Central District Court on June 30, challenging Hana Pharm's recent launching for marketing the generic versions of Oxycontin (oxycodone HCl) controlled release tablet

Mundi Pharma has alleged that Hana Pharm's formulation technology for Oxycontin infringes a number of its patents.

Oxycodone is a narcotic analges...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.